Cargando…
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Autores principales: | Yang, Yandan, Bolomsky, Arnold, Oellerich, Thomas, Chen, Ping, Ceribelli, Michele, Häupl, Björn, Wright, George W., Phelan, James D., Huang, Da Wei, Lord, James W., Van Winkle, Callie K., Yu, Xin, Wisniewski, Jan, Wang, James Q., Tosto, Frances A., Beck, Erin, Wilson, Kelli, McKnight, Crystal, Travers, Jameson, Klumpp-Thomas, Carleen, Smith, Grace A., Pittaluga, Stefania, Maric, Irina, Kazandjian, Dickran, Thomas, Craig J., Young, Ryan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530176/ https://www.ncbi.nlm.nih.gov/pubmed/36192480 http://dx.doi.org/10.1038/s41467-022-33618-w |
Ejemplares similares
-
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
por: Yang, Yandan, et al.
Publicado: (2022) -
Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021) -
Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4
por: Cheff, Dorian M., et al.
Publicado: (2023) -
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
por: Kumari, Anju, et al.
Publicado: (2023) -
Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation
por: Ooka, Masato, et al.
Publicado: (2022)